Back in September, The New York Times published an article about Turig Pharmaceuticals raising the price of the drug Deraprim by 5000 percent per tablet and the nefarious price-gouging chief executive behind that decision, Martin Shkreli. Deraprim is typically used to treat infections in people with compromised immune systems, like cancer patients and those who are HIV-positive. Though Shkreli bore the brunt of the internet’s criticism in the days after the Times first reported the story, some of that blame eventually trickled down to Collect Records founder Geoff Rickly (United Nations, No Devotion, Thursday). As Bullett pointed out, Shkreli is a long-time fan of pop-punk and emo music, and it eventually became pretty clear that he was the major investor backing Rickly’s label. Soon after this was uncovered, Collect Records announced that the label would sever ties with Shkreli.

We haven’t heard much about the ordeal since, but today, Rickly tweeted about a recent interview with Shkreli conducted by HIV activist Josh Robbins and uploaded to his site imstilljosh.com

Interesting interview between @imstilljosh and my old investor in @collectrecords — makes me wonder if we jumped too soon in cutting ties.

— Geoffrey Rickly (@GeoffRickly) November 3, 2015

Rickly then proceeded to comment a bit on the Shkreli controversy:

I think Capitalism as a whole can be pretty gruesome and Pharma especially.

— Geoffrey Rickly (@GeoffRickly) November 3, 2015

But I am starting to wonder where all the patients that have been denied access to Daraprim are.

— Geoffrey Rickly (@GeoffRickly) November 3, 2015

And–obviously– my first duty is to my bands and artists. To make them feel comfortable about being on an ethically responsible label. xx

— Geoffrey Rickly (@GeoffRickly) November 3, 2015

Their comfort and perception of safety can even trump reality. I live to serve art. I always have. And art is 99% perception.

— Geoffrey Rickly (@GeoffRickly) November 3, 2015

He then updated followers on the future of Collect Records, and mentioned that the label is seeking new investors:

Anyway, on the other side, @collectrecords is starting to bounce back. Finding new investors. Working on relaunching.

— Geoffrey Rickly (@GeoffRickly) November 3, 2015

The @WAXIDOLS record has been an unqualified success. Out of print already! And @nodevotionband charted!!! Didn't expect that!

— Geoffrey Rickly (@GeoffRickly) November 3, 2015

So regardless of the past, I'm looking forward to the future. And holding our ethics and art to a higher standard than we ever have. xx

— Geoffrey Rickly (@GeoffRickly) November 3, 2015